Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1967 4
1968 2
1969 1
1970 5
1971 5
1972 7
1973 3
1974 5
1975 2
1976 2
1977 1
1978 4
1979 2
1980 4
1981 4
1982 2
1983 5
1984 4
1985 3
1986 5
1989 1
1990 1
1991 1
1995 1
1998 3
1999 1
2001 3
2002 1
2005 1
2006 1
2010 1
2011 1
2012 2
2013 3
2014 1
2016 1
2019 1
2020 2
2021 3
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
The potential role of CacyBP/SIP in tumorigenesis.
Ning X, Chen Y, Wang X, Li Q, Sun S. Ning X, et al. Tumour Biol. 2016 Aug;37(8):10785-91. doi: 10.1007/s13277-016-4871-y. Epub 2016 Feb 13. Tumour Biol. 2016. PMID: 26873490 Review.
Calcyclin-binding protein/Siah-1-interacting protein (CacyBP/SIP) was initially described as a binding partner of S100A6 in the Ehrlich ascites tumor cells and later as a Siah-1-interacting protein. ...
Calcyclin-binding protein/Siah-1-interacting protein (CacyBP/SIP) was initially described as a binding partner of S100A6 in the Ehrlich
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
Singh D, Gupta M, Sarwat M, Siddique HR. Singh D, et al. Crit Rev Oncol Hematol. 2022 Aug;176:103751. doi: 10.1016/j.critrevonc.2022.103751. Epub 2022 Jun 22. Crit Rev Oncol Hematol. 2022. PMID: 35752426 Review.
RESULTS: A total of 25 studies focused on the anticancer effects of Apigenin on various cancer types, including liver, prostate, pancreatic, lung, nasopharyngeal, skin, colon, colorectal, colitis-associated carcinoma, head and neck squamous cell carcinoma, leukemia, …
RESULTS: A total of 25 studies focused on the anticancer effects of Apigenin on various cancer types, including liver, prostate, pancreatic, …
Measles virus in cancer therapy.
Mühlebach MD. Mühlebach MD. Curr Opin Virol. 2020 Apr;41:85-97. doi: 10.1016/j.coviro.2020.07.016. Epub 2020 Aug 28. Curr Opin Virol. 2020. PMID: 32861945 Review.
Because of its high genetic flexibility, a number of different MeV strains have been the basis for the generation of targeted, armed, or shielded viruses that are highly specific for a given tumor target, more effective, or protected against serum neutralization. ...Theref …
Because of its high genetic flexibility, a number of different MeV strains have been the basis for the generation of targeted, armed, or shi …
[Checkpoint inhibitors for cancer therapy].
Zander H, Müller-Egert S, Zwiewka M, Groß S, van Zandbergen G, Engelbergs J. Zander H, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Nov;63(11):1322-1330. doi: 10.1007/s00103-020-03221-9. Epub 2020 Oct 1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 33001218 Free PMC article. Review. German.
In recent years, a breakthrough in tumor therapy was achieved with the development of checkpoint inhibitors. ...This article provides an overview of the mode of action of approved checkpoint inhibitors and the status of current clinical development.The previously approved …
In recent years, a breakthrough in tumor therapy was achieved with the development of checkpoint inhibitors. ...This article provides …
Surgical Management of Wilms Tumor (Nephroblastoma) and Renal Cell Carcinoma in Children and Young Adults.
Lopyan NM, Ehrlich PF. Lopyan NM, et al. Surg Oncol Clin N Am. 2021 Apr;30(2):305-323. doi: 10.1016/j.soc.2020.11.002. Epub 2021 Jan 29. Surg Oncol Clin N Am. 2021. PMID: 33706902 Review.
This article reviews the epidemiology, pathophysiology, clinical presentation, and multimodality management of Wilms tumors and renal cell carcinoma in pediatric and young adults. Key renal Societe Internationale d'Oncologie Pediatrique and Children Oncology Group studies …
This article reviews the epidemiology, pathophysiology, clinical presentation, and multimodality management of Wilms tumors and renal cell …
Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges.
Libes J, Hol J, Neto JCA, Vallance KL, Tinteren HV, Benedetti DJ, Villar GLR, Duncan C, Ehrlich PF. Libes J, et al. Pediatr Blood Cancer. 2023 May;70 Suppl 2:e30343. doi: 10.1002/pbc.30343. Pediatr Blood Cancer. 2023. PMID: 37096796 Review.
Pediatric renal tumors account for 3%-11% of childhood cancers, the most common of which is Wilms tumor or nephroblastoma. Epidemiology plays a key role in cancer prevention and control by describing the distribution of cancer and discovering risk factors for cancer. ...
Pediatric renal tumors account for 3%-11% of childhood cancers, the most common of which is Wilms tumor or nephroblastoma. Epidemiolo …
The effect of antioxidants in Ehrlich Ascites Cancer.
Yılmaz S, Tokpınar A, Eroğlu E, Ateş Ş, Zahid R, Avnioğlu S, Bozkurt Ö, Nisari M. Yılmaz S, et al. Cell Mol Biol (Noisy-le-grand). 2021 Sep 29;67(2):20-24. doi: 10.14715/cmb/2021.67.2.4. Cell Mol Biol (Noisy-le-grand). 2021. PMID: 34817342 Review.
Although it has been reported in the literature that antioxidant supplements reduce tumor cells in some tumors or cause volume reduction in solid tumor sizes, there is no definite consensus. ...
Although it has been reported in the literature that antioxidant supplements reduce tumor cells in some tumors or cause volume reduct …
Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
Rumjanek VM, Maia RC, Salustiano EJ, Costa PRR. Rumjanek VM, et al. Anticancer Agents Med Chem. 2019;19(1):29-37. doi: 10.2174/1871520618666180420165128. Anticancer Agents Med Chem. 2019. PMID: 29692266 Review.
Given to mice, in vivo, LQB-118 affected the growth of melanoma, Ehrlich carcinoma and prostate cancer cells. Conversely, no general toxicity was observed in vivo, by biochemical, hematological, anatomical or histological parameters and toxicity in vitro against nor …
Given to mice, in vivo, LQB-118 affected the growth of melanoma, Ehrlich carcinoma and prostate cancer cells. Conversely, no g …
If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer.
Köhler J, Jänne PA. Köhler J, et al. Int J Mol Sci. 2021 Mar 16;22(6):3025. doi: 10.3390/ijms22063025. Int J Mol Sci. 2021. PMID: 33809660 Free PMC article. Review.
Non-small-cell lung cancer (NSCLC) with Kirsten rat sarcoma (KRAS) mutations has notoriously challenged oncologists and researchers for three notable reasons: (1) the historical assumption that KRAS is "undruggable", (2) the disease heterogeneity and (3) the shaping of the tum
Non-small-cell lung cancer (NSCLC) with Kirsten rat sarcoma (KRAS) mutations has notoriously challenged oncologists and researchers for thre …
Resolution and reconstitution of biological pathways from 1919 to 1984.
Racker E. Racker E. Fed Proc. 1983 Sep;42(12):2899-909. Fed Proc. 1983. PMID: 6309577 Review.
In 1945 Meyerhof prepared an extract from yeast that did not ferment unless an ATPase was added. An extract of Ehrlich ascites tumor cells that does not glycolyze in the presence of catalytic amounts of Pi and nucleotides without addition of an ATPase is presented a …
In 1945 Meyerhof prepared an extract from yeast that did not ferment unless an ATPase was added. An extract of Ehrlich ascites tum
101 results